Showing results (41-50 of 161) with videos related to
Sort By:
Pageof 17
Pharmacology & Therapeutics|May 5, 2022
The future of targeted kinase inhibitors in melanomaSigne Caksa, Usman Baqai, Andrew E AplinThe Journal of Investigative Dermatology|October 11, 2013
Resistance to RAF inhibitors revisitedEdward Hartsough, Yongping Shao, Andrew E AplinClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Playing the Melanoma EndgameJessica L F Teh, Andrew E AplinClinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2018
Arrested Developments: CDK4/6 Inhibitor Resistance and Alterations in the Tumor Immune MicroenvironmentJessica L F Teh, Andrew E AplinCellular Signalling|October 21, 2015
Mitotic-dependent phosphorylation of leukemia-associated RhoGEF (LARG) by Cdk1Michelle C Helms, Elda Grabocka, Matthew K Martz, et al.The Journal of Investigative Dermatology|May 20, 2011
Mechanisms of resistance to RAF inhibitors in melanomaAndrew E Aplin, Fred M Kaplan, Yongping ShaoCancer Research|January 15, 2021
Roles of the BAP1 Tumor Suppressor in Cell MetabolismAnna Han, Timothy J Purwin, Andrew E AplinMolecular Cancer Research : MCR|October 20, 2006
Genetic and expression aberrations of E3 ubiquitin ligases in human breast cancerCeshi Chen, Arun K Seth, Andrew E AplinTrends in Cancer|June 15, 2021
Metabolic Alterations and Therapeutic Opportunities in Rare Forms of MelanomaAnna Han, Zachary T Schug, Andrew E AplinThe Journal of Biological Chemistry|June 25, 2003
Adhesion-dependent activation of the ERK1/2 cascade is by-passed in melanoma cellsSean R Conner, Glynis Scott, Andrew E AplinPageof 17